Online citations, reference lists, and bibliographies.
← Back to Search

Children With Craniopharyngioma

R. Sorva
Published 1988 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
ABSTRACT. Pre‐ and postoperative growth was analyzed in 22 children with craniopharyngioma. In 19 children a growth failure preceded the diagnosis by a mean of 4 years. Six children were obese preoperatively. During the first 3 postoperative months relative weight increased 7gt;10% in 14/21 children (there was one surgical death). One year after surgery 13/21 were obese. Neither the size of the tumor nor the mode of surgery was decisive in the development of the obesity. Serum insulin and insulin‐like growth factor I (IGF‐I) were assessed in four children with growth hormone deficiency (GHD) who, after surgery for craniopharyngioma, were growing normally without GH substitution. One of them was normal in weight and had normal insulin and IGF‐I levels; the others were obese and had supranormal insulin and subnormal IGF‐I levels. One of the four and two other children with unsubstituted GHD reached final height SDS ‐0.8, ‐2.0 and ‐2.4. One child with normal postoperative GH response reached final height SDS ‐0.7. Final height SDS ≧‐2.5 was gained with GH substitution by 6/11 children. It was >2.0 SD below the height SDS expected from the heights of the parents in 7/11. An adequate monitoring of children's growth would lead to earlier diagnosis and probably better outcome.
This paper references
Heiskanen 0. Craniopharyngioma in children and adults. Correlations between radiological and clinical manifestations
R Sorva (1987)
Accepted Febr
Fetal brain growth: a proposed model for regulation by embryonic somatomedin
VR Sara (1981)
10.1007/BF00442445
Long-term follow-up of children with craniopharyngioma
N. Stahnke (2004)
10.1016/s0022-3476(80)80714-1
Precocious puberty after surgery for craniopharyngioma.
M. Yadav (1980)
10.1016/S0022-3476(74)80310-0
Growth with absent growth hormone by radioimmunoassay
P. Saenger (1974)
10.2337/diab.26.8.726
Hypothalamic Regulation of Insulin Release in Rhesus Monkeys
D. E. Hill (1977)
10.1016/0031-9384(80)90190-0
Adipose tissue lipoprotein lipase activity in rats with obesity-inducing hypothalamic knife cuts
B. Lowell (1980)
10.1016/S0031-3955(16)33669-0
Endocrine disorders associated with tumors of the pituitary and hypothalamus.
G. Costin (1979)
10.1530/ACTA.0.0820449
Somatomedin A in human serum, determined by radioreceptor assay.
K. Takano (1976)
10.1148/72.6.878
Radiographic Atlas of Skeletal Development of the Hand and Wrist
M. Maresh (1950)
10.1111/j.1365-2265.1976.tb01984.x
PROLACTIN AND SOMATOMEDIN STUDIES IN THE SYNDROME OF GROWTH HORMONE‐INDEPENDENT GROWTH
P. D. Gluckman (1976)
10.1210/JCEM-33-5-732
Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.
B. Desbuquois (1971)
10.1016/S0022-3476(68)80428-7
Iatrogenic hypopituitarism in craniopharyngioma: unexplained catch-up growth in three children.
F. Kenny (1968)
10.1016/S0140-6736(86)92316-0
GROWTH WITHOUT GROWTH HORMONE: EVIDENCE FOR A POTENT CIRCULATING HUMAN GROWTH FACTOR
MitchellE. Geffner (1986)
10.1111/j.1365-2265.1981.tb02969.x
GROWTH HORMONE TREATMENT IN CHILDREN WITH CRANIOPHARYNGIOMA: FINAL GROWTH STATUS
E. C. Burns (1981)
10.1210/JCEM-42-2-370
Craniopharyngioma: the role of insulin in promoting postoperative growth.
G. Costin (1976)
10.1016/S0026-0495(78)80006-7
Hyperinsulinemia in obesity syndromes: its metabolic consequences and possible etiology.
B. Jeanrenaud (1978)
Craniopharyngioma in Finland. A study of 123 cases
R Sorva (1986)
10.1097/00000441-198607000-00004
Outcome in Children with Normal Growth Following Removal of a Craniopharyngioma
S. Blethen (1986)
[Hypothalamic obesity].
A. Iannaccone (1952)
Evaluation of growth in children ( in Finnish )
R Sorva (1985)
Development of reproductive system
JM Tanner (1962)
10.1056/NEJM198311103091902
Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma.
H. Bucher (1983)
10.1259/0007-1285-49-579-206
Craniopharyngioma: based on 160 cases.
M. Banna (1976)
10.1210/JCEM-48-2-271
Immunoreactive somatomedin A in human serum.
K. Hall (1979)
10.1210/JCEM-55-5-999
Insulin-like growth factors in the fed and fasted states.
T. Merimee (1982)
10.1530/ACTA.0.0880099
Insulin test: precisions of and correlations between glucose and hormone responses.
S. Leisti (1978)
10.1007/BF00254505
Hypothalamic obesity
G. Bray (2004)
Crdniopharyngioma in children. Endocrine and visual outcome. Child's Nervous System
R Sorva (1988)
Use of polyethylene glycol to separate antibody - bound peptide hormones in radioimmunoassay
B Desbuquois (1971)
10.1001/ARCHPEDI.1968.02100020313014
Return of normal growth following removal of a craniopharyngioma.
S. Frasier (1968)
10.1210/JCEM-53-6-1247
Reduction of plasma immunoreactive somatomedin C during fasting in humans.
D. Clemmons (1981)
10.1016/S0022-3476(79)80095-5
Precocious puberty after surgery for craniopharyngioma.
M. Zachmann (1979)
10.1136/jcp.22.6.710
Use of activated charcoal in the radioimmunoassay of human growth hormone in plasma
H. Jacobs (1969)
10.1210/JCEM-35-1-13
Sulfation factor (somatomedin): an explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors.
J. Finkelstein (1972)
10.1530/ACTA.0.0940155
Somatomedin A levels in serum from healthy children and from children with growth hormone deficiency or delayed puberty.
K. Hall (1980)



This paper is referenced by
10.1007/s00381-019-04258-1
Outcomes following endoscopic endonasal resection of sellar and supresellar lesions in pediatric patients
Christoforos P. Koumas (2019)
10.1159/000368798
Longitudinal Changes in Body Mass Index in Children with Craniopharyngioma
M. J. Khan (2014)
10.3389/fendo.2011.00078
Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity
Clinton T. Elfers (2011)
10.1053/BEGA.2002.0320
Use of somatostatin receptor ligands in obesity and diabetic complications.
B. Boehm (2002)
10.1016/J.METABOL.2005.04.005
Current knowledge in the neurophysiologic modulation of obesity.
N. Angelopoulos (2005)
10.1002/oby.21067
Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity
C. Roth (2015)
10.1007/s11102-012-0451-3
Acute presentation of craniopharyngioma in children and adults in a Danish national cohort
E. H. Nielsen (2012)
An audit of endocrine dysfunction in children with craniopharyngiomas at Red Cross Children's Hospital and Groote Schuur Hospital from 1976 to 2004
Zakiyya Omarjee (2006)
10.1016/J.BRAINDEV.2007.07.011
Comparison of hypothalamopituitary axis dysfunction of intrasellar and third ventricular craniopharyngiomas in children
Yi-Yen Lee (2008)
10.1016/J.IJROBP.2004.12.071
Dose distribution outside of a sphere of P-32 chromic phosphorous colloid.
Charles D Hechtman (2005)
10.1136/adc.75.2.108
Growth and endocrine sequelae of craniopharyngioma.
C. J. Devile (1996)
10.1210/er.2009-0033
Mortality in patients with pituitary disease.
M. Sherlock (2010)
10.1159/000078295
Pharmacological Treatment of Childhood Obesity
C. Marcus (2004)
10.1530/EJE-08-0533
Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children.
M. Shaikh (2008)
Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children
M. Guftar (2008)
10.1210/JC.2002-021180
Risk factors for the development of obesity in children surviving brain tumors.
R. Lustig (2003)
10.3390/jcm4091774
Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention
C. Roth (2015)
10.1515/JPEM.2006.19.2.121
Weight Gain in Craniopharyngioma - A Model for Hypothalamic Obesity
Arik Ahmet (2006)
10.1001/ARCHPEDI.1993.02160250099030
Growth hormone deficiency in two siblings with Alström syndrome.
C. Alter (1993)
10.1210/jc.2012-3928
Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity.
É. Elowe-Gruau (2013)
10.1016/j.wneu.2017.02.095
Outcome of Radical Surgical Resection for Craniopharyngioma with Hypothalamic Preservation: A Single-Center Retrospective Study of 1054 Patients.
X. Shi (2017)
10.1201/9781420026634.CH9
Endocrine Disorders Associated with Pediatric Obesity
J. Yanovski (2005)
10.1016/S1695-4033(00)77418-2
Hipercrecimiento y déficit de hormona del crecimiento tras tratamiento para el craneofaringioma
J. P. L. Siguero (2000)
10.1515/jpem.2011.098
Studies of different female rat models of hypothalamic obesity
Clinton T. Elfers (2011)
10.1007/978-94-007-7217-5_7
Hyperinsulinemia Tends to Induce Growth Without Growth Hormone in Children with Brain Tumors After Neurosurgery
Norishi Ueda (2014)
10.1007/s00381-005-1246-x
Endocrine manifestations of craniopharyngioma
I. Halac (2005)
10.3389/fendo.2012.00023
Bariatric Surgery in Hypothalamic Obesity
Nathan C Bingham (2012)
10.1007/s11102-011-0349-5
Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery
Gabrielle Page-Wilson (2011)
10.1007/s40521-019-00216-z
Management of Pediatric Sinonasal and Skull Base Lesions
Charles A. Riley (2019)
Eating behaviour and neural representations of hunger and satiety in patients with acquired structural hypothalamic damage : a clinical and functional neuroimaging study
C. Steele (2018)
10.1080/0268869031000108864
Stereotactic radiosurgery XVII: recurrent intrasellar craniopharyngioma
A. S. Jackson (2003)
10.3171/JNS.2000.92.2.0255
Phase II evaluation of interferon α-2a for progressive or recurrent craniopharyngiomas
R. Jakacki (2000)
See more
Semantic Scholar Logo Some data provided by SemanticScholar